ZVSA Earnings Date: Nov 18, 2026 (Estimated) — ZyVersa Therapeutics, Inc.
OTC
Updated
When is ZVSA's next earnings date?
ZyVersa Therapeutics, Inc. (ZVSA) is expected to report Q3 2026 earnings on Wednesday, November 18, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company.
How did ZVSA do in its last earnings report?
In its most recent report on May 13, 2026 (Q1 2026), ZyVersa Therapeutics, Inc. posted EPS of -$0.22. Revenue was $0. The stock's 1-day post-earnings move was +0.0%.
How much does ZVSA stock move after earnings?
ZVSA beat EPS estimates in 4 of its last 5 reported quarters. Over the last 8 reports the stock moved an average of 3.1% (up or down) in the day after earnings.
About ZyVersa Therapeutics, Inc.
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | Q1 2026 | — | -0.22 | — | $0 | — | +0.00% | +0.00% | +0.00% |
| 2025-11-19 | Q3 2025 | — | -2.56 | — | $0 | — | +0.00% | +0.00% | +0.00% |
| 2025-08-13 | Q2 2025 | — | -0.46 | — | $0 | — | +0.00% | +0.00% | +0.00% |
| 2024-11-14 | Q3 2024 | -3.70 | -2.43 | +34.32% | $0 | ✅ Beat | -9.60% | -8.00% | -15.98% |
| 2024-08-09 | Q2 2024 | -3.75 | -3.31 | +11.73% | $0 | ✅ Beat | -5.63% | -6.62% | -12.58% |
| 2024-05-15 | Q1 2024 | -3.70 | -4.53 | -22.43% | $0 | ❌ Miss | -6.62% | -16.82% | -7.78% |
| 2024-03-25 | Q4 2023 | -42.80 | -0.25 | +99.42% | $0 | ✅ Beat | -1.96% | -8.43% | -31.04% |
| 2023-11-14 | Q3 2023 | -112.00 | -63.00 | +43.75% | $0 | ✅ Beat | -1.09% | -9.05% | -74.92% |
Showing last 8 quarters.